169 related articles for article (PubMed ID: 9600880)
1. A new approach to fighting cancer?
Sato TN
Proc Natl Acad Sci U S A; 1998 May; 95(11):5843-4. PubMed ID: 9600880
[No Abstract] [Full Text] [Related]
2. Are angiostatin and endostatin cures for cancer?
Harris AL
Lancet; 1998 May; 351(9116):1598-9. PubMed ID: 9620709
[No Abstract] [Full Text] [Related]
3. Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.
Hayes AJ; Li LY; Lippman ME
BMJ; 1999 Mar; 318(7187):853-6. PubMed ID: 10092266
[No Abstract] [Full Text] [Related]
4. [Angiostatin. A biological inhibitor of tumor angiogenesis].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 1997 Mar; 122(13):413-4. PubMed ID: 9138915
[No Abstract] [Full Text] [Related]
5. Anticancer drug targets: approaching angiogenesis.
Keshet E; Ben-Sasson SA
J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
[No Abstract] [Full Text] [Related]
6. Fighting cancer by attacking its blood supply.
Folkman J
Sci Am; 1996 Sep; 275(3):150-4. PubMed ID: 8701285
[No Abstract] [Full Text] [Related]
7. Angiogenesis: the unifying concept in cancer?
Saphir A
J Natl Cancer Inst; 1997 Nov; 89(22):1658-9. PubMed ID: 9390530
[No Abstract] [Full Text] [Related]
8. [Angiostatin and its antitumor activity].
Félez J; Jardí M; Arza B
Med Clin (Barc); 2000 Mar; 114(11):431-6. PubMed ID: 10786363
[No Abstract] [Full Text] [Related]
9. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
O'Reilly MS
EXS; 1997; 79():273-94. PubMed ID: 9002223
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenesis drugs target specific cancers, mechanisms.
Randal J
J Natl Cancer Inst; 2000 Apr; 92(7):520-2. PubMed ID: 10749899
[No Abstract] [Full Text] [Related]
11. New perspectives in clinical oncology from angiogenesis research.
Folkman J
Eur J Cancer; 1996 Dec; 32A(14):2534-9. PubMed ID: 9059344
[No Abstract] [Full Text] [Related]
12. Cancer research. A surprising partner for angiostatin.
Barinaga M
Science; 1999 Mar; 283(5409):1831. PubMed ID: 10206885
[No Abstract] [Full Text] [Related]
13. Starving cancer into submission. EntreMed, Inc.
Wells WA
Chem Biol; 1998 Apr; 5(4):R87-8. PubMed ID: 9571213
[No Abstract] [Full Text] [Related]
14. Inhibitors of angiogenesis enter phase III testing.
Nelson NJ
J Natl Cancer Inst; 1998 Jul; 90(13):960-3. PubMed ID: 9665141
[No Abstract] [Full Text] [Related]
15. Cancer 'cure' article stirs up hot debate.
Wadman M
Nature; 1998 May; 393(6681):104-5. PubMed ID: 9603508
[No Abstract] [Full Text] [Related]
16. [The story of angiostatin and how controversy is useful in science].
Kurjak A
Acta Med Croatica; 2003; 57(2):145-8. PubMed ID: 12879695
[TBL] [Abstract][Full Text] [Related]
17. Mouse hunt.
Gawande A
Minn Med; 1998 Aug; 81(8):10-2. PubMed ID: 9715627
[No Abstract] [Full Text] [Related]
18. Toward increased sensitivity and specificity in the treatment of neoplastic diseases.
Slavkin HC
J Am Dent Assoc; 1998 Apr; 129(4):473-8. PubMed ID: 9573699
[No Abstract] [Full Text] [Related]
19. [Antiangiogenic therapy].
Toi M
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900
[TBL] [Abstract][Full Text] [Related]
20. Cancer. Proteases--invasion and more.
Edwards DR; Murphy G
Nature; 1998 Aug; 394(6693):527-8. PubMed ID: 9707109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
